COEP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Coeptis Therapeutics Holdings Inc (COEP) is not a strong buy for a beginner investor with a long-term focus at this time. The lack of positive trading trends, neutral technical indicators, no significant news or catalysts, and weak financial performance suggest that waiting for clearer signals or stronger fundamentals would be prudent.
The MACD is slightly positive but contracting, RSI is neutral at 42.543, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 12.507, with key resistance at 13.592 and support at 11.422. Overall, the technical indicators suggest a neutral trend.
NULL identified. No recent news or significant insider or hedge fund activity.
Weak financial performance with negative net income and declining EPS. No recent congress trading data or significant trading trends.
In Q3 2025, revenue remained flat YoY, net income improved by 58.11% YoY but remains negative at -2739403, and EPS declined by -33.33% YoY to -0.58. Gross margin is negative at -24.31%. Overall, financials indicate weak performance.
No analyst rating or price target changes available.
